Lv5
830 积分 2025-04-22 加入
Comparison of Population Pharmacokinetics‐Related Information in Drug Labeling Between Japan, the United States, and the European Union
2天前
已完结
Operational Characteristics of Linear Concentration‐QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies
1个月前
已完结
Practical guide to concentration-QTc modeling: a hands-on tutorial
1个月前
已完结
Population Pharmacokinetics of Valemetostat and Exposure–Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T–Cell Lymphoma
1个月前
已完结
Valemetostat: First approval as a dual inhibitor of EZH1/2 to treat adult T-cell leukemia/lymphoma
1个月前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
1个月前
已完结
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study
1个月前
已完结
Oncology Combination Drug Development Strategies for Project Optimus
1个月前
已完结
皖公网安备34019202002308
